Abstract
Supravalvular aortic stenosis (SVAS) is a congenital heart disease that can occur as an iso-lated autosomal-dominant condition or as part of the developmental disorder Williams-Beuren syndrome (WBS) and is caused by heterozygous genetic lesions involving the elastin (ELN) gene locus on chromosome 7q11.23. SVAS is one of many phenotypic features associated with the contiguous gene microdeletion disorder, WBS, and is caused by deletion of the ELN locus on one chromosome 7 homolog. Point mutations, chromosomal deletions, and translocation involving ELN have also been described in individuals with nonsyndromic SVAS. In addition, ELN is involved in the connective tissue disorder, autosomal-dominant cutis laxa, and has been implicated as a susceptibility gene for hypertension and intracranial aneurysms. The molecular analysis of ELN defects is, therefore, an area of significant interest. Genetic screening can be achieved using a variety of techniques to detect both mutations and gross chromosome rear-rangements involving the ELN locus, providing the ability to screen families and individuals with SVAS and associated elastinopathies.
Key Words
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mecham, R. P. and Davis, E. C. (1994) Elastic fibre structure and assembly, in Extracellular Matrix Assembly and Structure (Yurchenko, P. D., Birk, D. E, and Mecham, R. P.,eds.), Academic, San Diego, CA, 281–314.
Indik, Z., Yeh, H., Ornstein-Goldstein, N., et al. (1989) Structure of the elastin gene and alternative splicing of elastin mRNA: implications for human disease. Am. J. Med. Genet. 34, 81–90.
Tassabehji, M., Metcalfe, K., Donnai, D., et al. (1997) Elastin: genomic structure and point mutations in patients with supravalvular aortic stenosis. Hum. Mol. Genet. 6, 1029–1036.
Williams, J. C., Barratt-Boyes, B. G., and Lowe, J. B. (1961) Supravalvular aortic stenosis. Circulation 24, 1311–1318.
Eisenberg, R., Young, D., Jacobson, B., and Boito, A. (1964) Familial supravalvular aortic stenosis. Am. J. Dis. Child. 108, 341–347.
Li, D. Y., Toland, A. E., Boak, B. B., et al. (1997) Elastin point mutations cause an obstructive vascular disease, supravalvular aortic stenosis. Hum. Mol. Genet. 6, 1021–1028.
Metcalfe, K., Rucka, A. K., Smoot, L., et al. (2000) Elastin: mutational spectrum in supravalvular aortic stenosis. Eur. J. Hum. Genet. 8, 955–963.
Urban, Z., Michels, V. V., Thibodeau, S. N., Donis-Keller, H., Csiszar, K., and Boyd, C. D. (1999) Supravalvular aortic stenosis: a splice site mutation within the elastin gene results in reduced expression of two aberrantly spliced transcripts. Hum. Genet. 104, 135–142.
Urban, Z., Michels, V. V., Thibodeau, S. N., et al. (2000) Isolated supravalvular aortic stenosis: functional haploinsufficiency of the elastin gene as a result of nonsense-mediated decay. Hum. Genet. 106, 577–588.
Urban, Z., Zhang, J., Davis, E. C., et al. (2001) Supravalvular aortic stenosis: genetic and molecular dissection of a complex mutation in the elastin gene. Hum. Genet. 109, 512–520.
Urban, Z., Riazi, S., Seidl, T. L., et al. (2002) Connection between elastin haploinsufficiency and increased cell proliferation in patients with supravalvular aortic stenosis and Williams-Beuren syndrome. Am. J. Hum. Genet. 71, 30–44.
Curran, M. E., Atkinson, D. L., Ewart, A. K., Morris, C. A., Leppert, M. F., and Keating, M. T. (1993) The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis. Cell 73, 159–168.
Ewart, A. K., Jin, W., Atkinson, D., Morris, C. A., and Keating, M. T. (1994) Supravalvular aortic stenosis associated with a deletion disrupting the elastin gene. J. Clin. Invest. 93, 1071–1077.
Olson, T. M., Michels, V. V., Urban, Z., et al. (1995) A 30 kb deletion within the elastin gene results in familial supravalvular aortic stenosis. Hum. Mol. Genet. 4, 1677–1679.
Tassabehji, M., Metcalfe, K., Karmiloff-Smith, A., et al. (1999) Williams syn-drome: use of chromosomal microdeletions as a tool to dissect cognitive and physical phenotypes. Am. J. Hum. Genet. 64, 118–125.
Tassabehji, M., Metcalfe, K., Hurst, J., et al. (1998) An elastin gene mutation producing abnormal tropoelastin and abnormal elastic fibres in a patient with auto-somal dominant cutis laxa. Hum. Mol. Genet. 7, 1021–1028.
Zhang, M. C., He, L., Giro, M., Yong, S. L., Tiller, G. E., and Davidson, J. M. (1999) Cutis laxa arising from frameshift mutations in exon 30 of the elastin gene (ELN). J. Biol. Chem. 274, 981–986.
Rodriguez-Revenga, L., Iranzo, P., Badenas, C., Puig, S., Carrio, A., and Mila, M. (2004) A novel elastin gene mutation resulting in an autosomal dominant form of cutis laxa. Arch. Dermatol. 140, 1135–1139.
Urban, Z., Gao, J., Pope, F. M., and Davis, E. C. (2005) Autosomal dominant cutis laxa with severe lung disease: sythesis and matrix deposition of mutant tropoelastin. J. Invest. Dermatol. 124, 1193–1199.
Onda, H., Kasuya, H. Yoneyama, T., et al. (2001) Genomewide-linkage and hap-lotype-association studies map intracranial aneurysm to chromosome 7q11. Am. J. Hum. Genet. 69, 804–819.
Suggs, S. V., Wallace, R. B., Hirose, T., Kawashima, E. H., and Itakura, K. (1981) Use of synthetic oligonucleotides as hybridization probes: isolation of cloned cDNA sequences for human beta 2-microglobulin. Proc. Natl. Acad. Sci. USA 78, 6613–6617.
Bassam, B. J., Caetano-Anolles, G., and Gresshoff, P. M. (1991) Fast and sensi-tive silver staining of DNA in polyacrylamide gels. Anal. Biochem. 196, 80–83.
Foster, K., Ferrell, R., King-Underwood, L., et al. (1993) Description of a dinucleotide repeat polymorphism in the human elastin gene and its use to con-firm assignment of the gene to chromosome 7. Ann. Hum. Genet. 57(Pt 2), 87–96.
Urban, Z., Csiszar, K., Fekete, G., and Boyd, C. D. (1997) A tetranucleotide repeat polymorphism within the human elastin gene (ELNi1). Clin. Genet. 51, 133–134.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Tassabehji, M., Urban, Z. (2006). Congenital Heart Disease. In: Kearns-Jonker, M. (eds) Congenital Heart Disease. Methods in Molecular Medicine, vol 126. Humana Press. https://doi.org/10.1385/1-59745-088-X:129
Download citation
DOI: https://doi.org/10.1385/1-59745-088-X:129
Publisher Name: Humana Press
Print ISBN: 978-1-58829-375-6
Online ISBN: 978-1-59745-088-1
eBook Packages: Springer Protocols